Company Encyclopedia
View More
name
GMF
002551.SZ
Shenzhen Glory Medical Co.,Ltd. offers hospital construction and medical system integrated solutions in China and internationally. It operates through Medical Products, Medical Services, and Health Industry segments. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering projects; and medical software development activities.
1.833 T
002551.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Construction and EngineeringIndustry
Industry Ranking67/112
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-1.06%D
    • Profit Margin-2.30%D
    • Gross Margin9.40%E
  • Growth ScoreD
    • Revenue YoY-6.08%D
    • Net Profit YoY81.33%A
    • Total Assets YoY-9.05%E
    • Net Assets YoY-1.13%D
  • Cash ScoreE
    • Cash Flow Margin-4349.11%E
    • OCF YoY-6.08%D
  • Operating ScoreD
    • Turnover0.32D
  • Debt ScoreB
    • Gearing Ratio23.31%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    GMF: Net profit loss of 27.367 million yuan in the third quarter, a decrease of 4,004.28%

    GMF announced that its revenue for the third quarter was 225 million yuan, a decrease of 39.25%; the net profit loss was 27.367 million yuan, a decrease of 4,004.28%. Revenue for the first three quarters was 754 million yuan, a decrease of 24.85%; the net profit loss was 35.1253 million yuan, a decrease of 338.50%

    Zhitong·
    SZ
    002551
    +1.55%
    Zhitong·
    SZ
    002551
    +1.55%

    August 8th Midday Review: ChiNext Index rose 0.21% in half a day, and the Yajiang Hydropower concept collectively strengthened

    On August 8th, at the midday close, the three major indices rose slightly, with the Shanghai Composite Index up 0.07%, the Shenzhen Component Index up 0.14%, and the ChiNext Index up 0.21%. The Yajiang hydropower concept stocks performed strongly, with multiple stocks hitting the daily limit; the commercial aerospace and medical device sectors were also active, with SINOMED and GMF hitting the daily limit. In contrast, AI intelligent body concept stocks adjusted, with Jinxiandai and Dingjie Shuzhi falling over 10%. Overall, the market saw more stocks decline than rise, with a total turnover of 1.09 trillion

    Wallstreetcn·
    SZ
    002551
    +1.55%
    SH
    688108
    +1.12%
    SZ
    399006
    +1.36%
    Wallstreetcn·
    SZ
    002551
    +1.55%
    SH
    688108
    +1.12%
    SZ
    399006
    +1.36%

    The healthcare sector rises, GMF and JIAODA ONLLY hit the daily limit

    The healthcare sector is rising, GMF has hit the limit up, JIAODA ONLLY previously hit the limit up, and BGI Genomics, Anbiping, and Dian Diagnostics are among the top gainers

    Zhitong·
    SZ
    002551
    +1.55%
    SH
    600530
    +1.67%
    Zhitong·
    SZ
    002551
    +1.55%
    SH
    600530
    +1.67%

    The healthcare sector rises, GMF hits the limit up

    The healthcare sector surged, with GMF hitting the limit up, followed by JIAODA ONLLY, SONOSCAPE, ZHYL, BGI Genomics, and Bioeasy among the top gainers

    Zhitong·
    SZ
    300942
    +0.91%
    SH
    600530
    +1.67%
    SZ
    002551
    +1.55%
    Zhitong·
    SZ
    300942
    +0.91%
    SH
    600530
    +1.67%
    SZ
    002551
    +1.55%

    GMF: In 2024, the net profit is 22.282 million yuan, a year-on-year increase of 114.97%

    GMF announced that the operating revenue for 2024 is expected to be 1.448 billion yuan, a year-on-year increase of 21.40%. The net profit attributable to shareholders of the listed company is 22.282 million yuan, a year-on-year increase of 114.97%. The basic earnings per share is 0.0264 yuan/share. The company plans to distribute a cash dividend of 0.08 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve converted into share capital

    Zhitong·
    SZ
    002551
    +1.55%
    Zhitong·
    SZ
    002551
    +1.55%
    © 2025 Longbridge｜Disclaimer